Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-11
2009-08-18
Tate, Christopher R. (Department: 1655)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S454000, C514S455000, C549S264000, C549S334000, C424S736000
Reexamination Certificate
active
07576124
ABSTRACT:
Safe, effective first-pass inhibiting compounds and citrus-derived substances are provided. Formulations containing the compounds are also provided as are methods for their preparation and for inhibiting the first pass effect.
REFERENCES:
patent: 5061502 (1991-10-01), Cally et al.
patent: 5820915 (1998-10-01), Harris
patent: 5962044 (1999-10-01), Harris
patent: 5990154 (1999-11-01), Harris
patent: 5993887 (1999-11-01), Harris
patent: 6054477 (2000-04-01), Harris
patent: 6063809 (2000-05-01), Harris
patent: 6124477 (2000-09-01), Harris
patent: 6162479 (2000-12-01), Harris
patent: 6248776 (2001-06-01), Harris
patent: 6255337 (2001-07-01), Harris
patent: 6309687 (2001-10-01), Harris
patent: 6476066 (2002-11-01), Harris
patent: 6613918 (2003-09-01), Seemayer et al.
patent: 6660766 (2003-12-01), Harris
patent: 7230027 (2007-06-01), Harris
patent: 2003/0235632 (2003-12-01), Harris
patent: 2004/0058982 (2004-03-01), Harris
patent: 2005/0171191 (2005-08-01), Harris
patent: 2007/0287664 (2007-12-01), Ralston et al.
patent: 1 084 733 (1960-07-01), None
patent: 57-179186 (1982-11-01), None
patent: 62-75450 (1987-04-01), None
patent: 62-80642 (1987-04-01), None
patent: 62-173456 (1987-07-01), None
patent: 62-173457 (1987-07-01), None
patent: WO 95/02589 (1995-01-01), None
patent: WO 98/07332 (1998-02-01), None
Ohta et al. Tetrahedron. 2002. vol. 58, pp. 6631-6635.
Guo et aol. Drug Metabolism and Disposition. 2000. vol. 28, No. 7, pp. 766-771.
Kozo Sato et al.; “Reactions of Coumarin Diethyl Acetal with Nucleophiles”; Studies on the Synthesis of Spiropyran Derivatives. III.; vol. 92: 180942q; 1980.
Kurt Bodenbenner; “Spirocyclic Ortho Esters”; (Bayer Akt. Ges., Leverkusen, Ger.). Ann. 623; pp. 183-191; 1959.
E.E. van Tamelen et al.; “Biogenetic-Type Total Synthesis of (±)-Farnesiferol A and (±)-Farnesiferol C”; Bioorganic Chemistry 11, 171-196; 1982.
David J. Collins et al.; “Enolic Ortho Esters I Preparation and Birch Reduction of Some Coumarinoid Ortho Esters”; Aust. J. Chem., 1989; 42, 1235-48.
Yong-Qing Xiao et al.; “Bicoumarins From Pleurospermum Rivulorum”; Phytochemistry, vol. 45, No. 6, pp. 1275-1277; 1997.
Masahiko Taniguchi et al.; “Rivulotririns A and B from Pleurospermum rivulorum”; Chem. Pharm. Bull.; vol. 46, No. 12, pp. 1946-1947; 1998.
Masahiko Taniguchi et al.; “Rivulobirins C and D, Two Novel New Spirobicoumarins, From the Underground Part of Pleurospermum Rivulorum”; Chem. Pharm. Bull.; vol. 46, No. 6, pp. 1065-1067; 1998.
Teemu Kantola; Clinical Pharmacology & Therapeutics: “Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid”; vol. 63, No. 4; pp. 397-402; Apr. 1998.
Jari J. Lilja; Clinical Pharmacology & Therapeutics; “Grapefruit juice substantially increases plasma concentrations of buspirone”; vol. 64, No. 6; pp. 655-660; Dec. 1998.
Jari J. Lilja; Clinical Pharmacology & Therapeutics; “Grapefruit juice-simvastatin interaction; Effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors”; vol. 64, No. 5; pp. 477-483; Nov. 1998.
Stephen Cross; Proc. Fla. State Hort. Soc. “Membrane Concentration of Orange Juice”; vol. 102, pp. 146-152, 1989.
Ernesto Hernandez; J. Agric. Food Chem. “Ultrafiltration of Orange Juice: Effect on Soluble Solids, Suspended Solids, and Aroma”; vol. 40, No. 6, pp. 986-988; 1992.
G. Capannelli; Lebensm-Wiss. U.-Technol. “Ultrafiltration of Fresh Orange and Lemon Juices”; vol. 25, No. 6, pp. 518-522; 1992.
J.R. Johnson; Journal of Food and Science; “Flavor Losses in Orange Juice during Ultrafiltration and Subsequent Evaporation”; vol. 61, No. 3, pp. 540-543; 1996.
E. Hernandez; Journal of Food and Science; “Evaluation of Ultrafiltration and Absorption to Debitter Grapefruit Juice and Grapefruit Pulp Wash”; vol. 57, No. 3, pp. 664-670; 1992.
Search Request Letter; Jan. 22, 1999.
Search Results; Answers 1-12; Jan. 22, 1999.
Sato Kozo, et al.; “Studies on the synthesis of spiropyran derivatives. III. Reactions of coumarin diethyl acetal with nucleophiles”; (Fac. Eng., Tokyo Inst. Technol., Tokyo, Japan); Nippon Kagaku Kaishi, No. 3, pp. 492-496 (Japanese); 1976 (w/attached English Abstract).
Kurt Bodenbenner, et al.; “Bicyclic acetals”; Chemical Abstracts; vol. 55, pp. 20963, 1962.
Bioavailability Systems, L.L.C.
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
Tate Christopher R.
LandOfFree
Anti-first-pass effect compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-first-pass effect compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-first-pass effect compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4098681